Investigational Treatment Studies

ADRC Home >> Investigational Treatment Studies

Alzheimer’s Disease Research Center
University of Washington
Veterans Affairs Puget Sound Health Care System

This spring the Alzheimer’s Disease Research Center (ADRC) will be enrolling research participants in several new investigational treatment studies. Finding treatments that actually change the disease process in the body is the focus of this new research.

Currently the only available prescriptions for the treatment of Alzheimer’s disease are medications that are mostly aimed at helping with the symptoms of Alzheimer’s disease such as memory loss and trouble thinking.

Investigational drugs are now being studied to see if they will slow down or stop the changes that occur in the brains of people with this disease. The ADRC is currently screening potential participants for these studies which will begin enrollment during the next six months. Research participation will not cost you anything, and is open to all members of the public. Some research participants will receive a placebo (a treatment without active medication) for at least some portion of the research.

To participate, individuals must:

Be age 50 or older
Have a diagnosis of mild to moderate Alzheimer’s disease
Be living at home (one study will allow residents of assisted living centers to participate)
Have a companion who can accompany the participant to all research visits

All research visits are at the Seattle Veterans Affairs Medical Center on Beacon Hill.

For more information, please call the UW Alzheimer’s Disease Research Center at: 206-764-2069 or 1-800-317-5382.

adrcweb@u.washington.edu
Please remember that we cannot guarantee the confidentiality of any information sent by email.
UW ADRC Director--Murray Raskind, M.D.
UW ADRC Education and Training Director--Linda Teri, Ph.D.
Last Modified: Sunday, 16-Mar-2008 17:28:41 PDT